REPLIGEN CORP Gain (Loss) on Investments
REPLIGEN CORP (RGEN) reported Gain (Loss) on Investments of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-26.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2020-02-26
- REPLIGEN CORP gain (loss) on investments for the quarter ending 2017-06-30 was $0.00.
- REPLIGEN CORP gain (loss) on investments for the quarter ending 2017-03-31 was $0.00.
- REPLIGEN CORP gain (loss) on investments for the quarter ending 2016-12-31 was $0.00.
- REPLIGEN CORP gain (loss) on investments for the quarter ending 2016-09-30 was $0.00.
- REPLIGEN CORP gain (loss) on investments for fiscal 2018 was $0.00.
- REPLIGEN CORP gain (loss) on investments for fiscal 2017 was $0.00.
- REPLIGEN CORP gain (loss) on investments for fiscal 2016 was $0.00.
- REPLIGEN CORP gain (loss) on investments for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2020-02-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-26 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2017-08-03 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-02-22 | $0.00 derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-22 | $0.00 derived: sum of 3 quarters · filed 2018-02-22 | $0.00 derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $0.00 derived: sum of 2 quarters · filed 2018-02-22 | $0.00 derived: sum of 3 quarters · filed 2018-02-22 | $0.00 10-K · filed 2018-02-22 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $0.00 derived: sum of 2 quarters · filed 2015-11-05 | $0.00 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-08 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-25 | |||
| 2013-01-31 | $0.00 10-K · filed 2015-03-17 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-14 | |||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |